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From the Managing Editor 
A Call to Forward-Thinking Bioethics 
 
Heather G. Kuruvilla, Ph.D. 
Cedarville University 
 
It is said that hindsight is always 20/20.  However, a reasoned approach to practical bioethics requires an 
awareness of developing technologies and their potential applications to clinical practice.  As a recent 
example, the powerful gene editing technology, CRISPR/Cas 9 has been widely used in the laboratory 
both to repair genetic defects and to disrupt gene expression.  When Liang et al. 1 published their study on 
April 18, which used CRISPR to edit non-viable human zygotes, a firestorm of debate ensued.   
The data obtained by Liang et al. indicate a low editing efficiency in the embryos, as well as a high 
number of off-target mutations.2  As reported to Nature, one of the scientists in the study, Dr. Huang, 
noted, “That’s why we stopped [the research].  It [the technology is] is still too immature.”3 
Other scientists remain convinced that such research on the human germline should not be allowed at 
present.  For example, Lanphier and his colleagues, who use CRISPR to modify somatic cells, believe 
that using CRISPR on germ-line cells could have unpredictable, potentially harmful effects on future 
generations of human beings.4   However, they cite several examples of CRISPR-based somatic cell 
therapies in various stages of development, including a treatment for β-thassalemia that is scheduled to 
begin phase I trials later this year.5  
While using genetically modified somatic cells certainly raises concerns of safety and efficacy, those 
concerns are limited to the individual being treated.  Our current protocols for clinical trials are designed 
to address such questions.  But the possibility of causing heritable genetic damage remains one of the 
major reasons that many nations, including the US, ban research that modifies the human germline.    
The technical difficulties encountered by Liang and colleagues open up the floor for meaningful 
bioethical discussion.  Now is the time to address deep issues of what it means to be human.  Are 
concerns about modifying the human germline simply limited to safety and efficacy?  If so, such concerns 
will likely be resolved as technology improves.  And the technology is likely to improve quickly, as other 
scientists continue this research and perfect their protocols.  Nature news writer David Cyranoski noted in 
his March 18th article that several research teams are nearing publication of work similar to the study 
published by Liang et al.6 
However, beyond the safety concerns lie deeper questions. Certainly the ability to edit the genome brings 
with it all kinds of therapeutic possibilities.  At the same time, there is no reason why someone could not 
use this technology to modify the human species, with good or evil intent.  Our genetics are an integral 
part of what make us human.  We now hold tools which would allow modification of the human genome 
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on a much faster time frame than we have ever observed in nature.  If we believe that modification of the 
human genome should be restricted to therapeutic uses, or even banned altogether, now is the time to 
frame those arguments.  Now is the time for theoreticians and pragmatists to join forces, talk through the 
issues, and set policies.  Regulations and laws need to be passed before embryonic human lives are 
irreversibly impacted.   
How does our use of genetic technology impact us as human persons, and as a biological species?  The 
window for discussion of these issues is closing as the technology continues to progress.  It is time to 
speak up, or forever hold our peace. 
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